-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On April 7, Renfu Medicine issued an announcement stating that its holding subsidiary, Yichang Renfu, had recently received an approval number from the US FDA for memantine hydrochloride sustained-release capsules.
Memantine hydrochloride sustained-release capsules are used to treat moderate to severe Alzheimer's disease dementia.
Allergan Company holds seven patents of Memantine Hydrochloride Sustained Release Capsules.
According to statistics from IQVIA, the total sales of the drug in the US market in 2020 will be approximately 61 million U.